Genetic diversity of influenza A(H3N2) viruses in Northern Cameroon during the 2014-2016 influenza seasons.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
08 2019
Historique:
received: 28 09 2018
revised: 05 02 2019
accepted: 06 02 2019
pubmed: 14 3 2019
medline: 3 6 2020
entrez: 14 3 2019
Statut: ppublish

Résumé

In Cameroon, genome characterization of influenza virus has been performed only in the Southern regions meanwhile genetic diversity of this virus varies with respect to locality. The Northern region characterized by a Sudan tropical climate might have distinct genetic characterization. This study aimed to better understand the genetic diversity of influenza A(H3N2) viruses circulating in Northern Cameroon. Sequences of three gene segments (hemagglutinin (HA), neuraminidase (NA) and matrix (M) genes) were obtained from 16 A(H3N2) virus strains collected during the 2014 to 2016 influenza seasons in Garoua. The HA gene segments were analysed with respect to reference strains while the NA and M gene was analysed for reported genetic markers of resistance to antivirals. Analysis of the HA sequences revealed that majority of the virus strains grouped together with the 2016-2017 vaccine strain (3C.2a-A/Hong Kong/4801/2014) while 3/5 (60%) of the 2015 viral strains grouped together with the 2015-2016 vaccine strain 3C.3a-A/Switzerland/9715293/2013. Within clade 3C.2a, Northern Cameroon sequences mostly grouped in sub-clade A3 (10/16). Analysis of the coding regions of the NA and M genes showed that none had genetic markers of resistance to neuraminidase inhibitors but all strains possessed the S31N substitution of resistance to amantadine. Due to some discrepancies observed in this region with respect to the Southern regions of Cameroon, there is necessity of including all regions within a country in the sentinel surveillance of influenza. These data will enable to track changes in influenza viruses in Cameroon.

Identifiants

pubmed: 30866072
doi: 10.1002/jmv.25456
doi:

Substances chimiques

Hemagglutinin Glycoproteins, Influenza Virus 0
M1 protein, Influenza A virus 0
Viral Matrix Proteins 0
Viral Proteins 0
NA protein, influenza A virus EC 3.2.1.18
Neuraminidase EC 3.2.1.18

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1400-1407

Subventions

Organisme : WHO PIP Implementation in Cameroon
Pays : International
Organisme : U.S. Department of Health and Human Services
ID : 6 DESP060001-01-01
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Hermann Landry Munshili Njifon (HLM)

National Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon, PO Box 1274, Yaoundé, Cameroon.
Centre Pasteur of Cameroon, Annex of Garoua, PO Box 921, Garoua, Cameroon.
Faculty of Science, University of Yaoundé 1, P.O Box 812, Yaoundé, Cameroon.

Chavely Gwladys Monamele (CG)

National Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon, PO Box 1274, Yaoundé, Cameroon.

Marie-Astrid Vernet (MA)

National Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon, PO Box 1274, Yaoundé, Cameroon.

Mohamadou Ripa Njankouo (MR)

National Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon, PO Box 1274, Yaoundé, Cameroon.

Louis Deweerdt (L)

Centre Pasteur of Cameroon, Annex of Garoua, PO Box 921, Garoua, Cameroon.

Raphael Nono (R)

Centre Pasteur of Cameroon, Annex of Garoua, PO Box 921, Garoua, Cameroon.

Sebastien Kenmoe (S)

National Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon, PO Box 1274, Yaoundé, Cameroon.

Wilfred Mbacham (W)

Faculty of Science, University of Yaoundé 1, P.O Box 812, Yaoundé, Cameroon.

Richard Njouom (R)

National Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon, PO Box 1274, Yaoundé, Cameroon.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH